AFT grows share price with US market approval

+Business
In print
Business

AFT grows share price with US market approval

Jonathan
Chilton-Towle
Hartley Atkinson
AFT managing director Hartley Atkinson
THE NEW ZEALAND share market has reacted positively to the news that AFT Pharmaceuticals’ flagship product Maxigesic was approved for sale in the US.